Non-alcoholic Fatty Liver Diseases (NAFLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASH
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Drug: GSK4532990 Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials

The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A
Conditions: NAFLD Interventions: Dietary Supplement: Soy isoflavone; Other: Placebo Sponsors: Ahvaz Jundishapur University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study
Conditions: Liver Cirrhosis; Non-Alcoholic Fatty Liver Disease; Hepatocellular Carcinoma Interventions: Diagnostic Test: Handgrip strength test; Diagnostic Test: total body Dual Energy X-Ray Absorptiometry (DXA); Diagnostic Test: Muscle ultrasound Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Device: abdominal U/S; Device: Fibroscan with Controlled Attenuated Parameter (CAP scan): Sponsors: Zagazig University; Suez University; Benha University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Biomarkers in the Diagnosis and Prognosis of NAFLD
Conditions: NAFLD; Obesity; Liver Fibrosis; Diabetes Mellitus, Type 2 Interventions: Diagnostic Test: Plasma Test; Diagnostic Test: Plasma test; Diagnostic Test: Plasma test; Diagnostic Test: Plasma test; Diagnostic Test: Liver biopsy; Diagnostic Test: Visceral adipose tissue biopsy; Diagnostic Test: Liver elastography; Diagnostic Test: Blood test Sponsors: University of Trieste Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Ultrasound Liver Fat Quantification on Pediatric Patients
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Device: 2D ultrasound scan and MRI examination Sponsors: Philips (China) Investment CO., LTD; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials

UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)
Conditions: Non Alcoholic Fatty Liver Disease Interventions: Diagnostic Test: UDFF Sponsors: University Hospital, Angers Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Probiotic Supplementation IN NAFLD Patients
Conditions: NAFLD Interventions: Drug: Control Test Sponsors: Ain Shams University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials

Liver Fat Content and Bariatric Surgery
Conditions: Non-Alcoholic Fatty Liver Disease; Bariatric Surgery; Magnetic Resonance Imaging Interventions: Other: We do not have any intervention type Sponsors: yu li ，MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials

Effect of Timed-Restricted Eating on Metabolic Health
Conditions: Obesity; Non-Alcoholic Fatty Liver Disease; Insulin Resistance Interventions: Behavioral: Early time restricted eating; Behavioral: Late time restricted eating Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Diabetesfonds Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
Conditions: Schizophrenia; Treatment-resistant Schizophrenia; Side Effect; Lipid Metabolism Disorders; Diabetes; NAFLD; Psychosis Interventions: Drug: Aripiprazole; Drug: Paliperidone Sponsors: Consorcio Centro de Investigaci ón Biomédica en Red (CIBER); Instituto de Salud Carlos III Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes
Conditions: Type 2 Diabetes; Pre Diabetes; Obstructive Sleep Apnea; Non-Alcoholic Fatty Liver Disease; Heart Failure Sponsors: University of Liverpool Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects
Condition: Nonalcoholic Fatty Liver Disease Interventions: Drug: Anti-human CCL24 monoclonal antibody (CM-101) - Part One; Drug: Anti-human CCL24 monoclonal antibody (CM-101) - Part Two; Drug: Placebo - Study Part One; Drug: Placebo - Study Part Two Sponsor: ChemomAb Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption
Conditions: NAFLD; MASLD; Mild Inflammatory Context Intervention: Dietary Supplement: TOTUM-448 Sponsors: Valbiotis; Clinic'n'Cell; University Hospital, Clermont-Ferrand Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials